Peptide Vials (Tesamorelin, 10 mg each): 8 weeks 11 vials (105 mg total) 12 weeks 17 vials (161 mg total) 16 weeks 22 vials (217 mg total) Insulin Syringes (U-100, 1 mL capacity): Per week: 7 syringes (1/day) 8 weeks: 56 syringes 12 weeks: 84 syringes 16 weeks: 112 syringes Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution
Menstrual cycle timing may affect response, with some women reporting better results when beginning protocols at specific cycle phases
Seiwerth, S., Milavic, M., Vukojevic, J., Gojkovic, S., Krezic, I., Vuletic, L
BPC-157 DOSING & ADMINISTRATION BPC-157 is administered as a subcutaneous injection
[1] Other causes include autoimmune conditions, certain infections, and inflammatory states that alter B12 metabolism or binding protein production